Research Topics
| Lois B TravisSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Second cancers among 40,576 testicular cancer patients: focus on long-term survivorsLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1354-65. 2005..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors...- Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphomaLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1428-37. 2005..We estimated this future risk, taking into account age and calendar year of HL diagnosis, HL treatment information, population breast cancer incidence rates, and competing causes of death... - Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendationsLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
J Natl Cancer Inst 98:15-25. 2006..These research areas warrant high priority to promote NCI's goal of eliminating pain and suffering related to cancer... - Therapy-associated solid tumorsLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
Acta Oncol 41:323-33. 2002..Thus, the benefit derived from many cancer therapies far outweighs any risk of developing a second cancer... - Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patientsSara J Schonfeld
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-7238, USA
J Natl Cancer Inst 98:215-8. 2006..The EAR of AML declined statistically significantly after 1984 (7.0 to 4.2 and 16.4 to 9.9 in the < 35 and > or = 35 age groups, respectively), which may be associated with modifications in chemotherapy... - Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term riskAnil K Chaturvedi
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
J Natl Cancer Inst 99:1634-43. 2007.... 
Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patientsRegan Howard
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Ann Epidemiol 18:416-21. 2008..The aim of this study is to quantify excess absolute risk (EAR) and excess relative risk (ERR) of secondary leukemia among a large population-based group of testicular cancer survivors...- Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin diseaseLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
JAMA 290:465-75. 2003..Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk... - Risk of second non-hematological malignancies among 376,825 breast cancer survivorsLinda Morris Brown
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd, MSC 7244, Bethesda, MD 20892 7244, USA
Breast Cancer Res Treat 106:439-51. 2007.... 
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factorsDeirdre A Hill
Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Blood 106:3358-65. 2005..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women...- Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 yearsGraca M Dores
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, Suite 7039, Bethesda, MD 20892, USA
J Clin Oncol 20:3484-94. 2002.... - Lung cancer following chemotherapy and radiotherapy for Hodgkin's diseaseLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
J Natl Cancer Inst 94:182-92. 2002..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use... - Leukemia following breast cancer: an international population-based study of 376,825 womenRegan A Howard
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7091, Bethesda, MD 20892, USA
Breast Cancer Res Treat 105:359-68. 2007.... - Suicide after breast cancer: an international population-based study of 723,810 womenCatherine Schairer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rm 8020, MSC 7244, Rockville, MD 20852 7244, USA
J Natl Cancer Inst 98:1416-9. 2006..08) and remained elevated among women diagnosed between 1990 and 2001 (SMR = 1.36, 95% CI = 1.18 to 1.57). The cumulative probability of suicide was 0.20% 30 years after breast cancer diagnosis... - Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren
Division of Cancer Epidemiology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Blood 113:4992-5001. 2009..Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial... - The epidemiology of second primary cancersLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Executive Plaza South, Suite 7086, Bethesda, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 15:2020-6. 2006.... - Second cancers after squamous cell carcinoma and adenocarcinoma of the cervixAnil K Chaturvedi
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
J Clin Oncol 27:967-73. 2009..We assessed whether these cofactor differences translate into differences in second cancer risk... - Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancersCatherine Schairer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
J Natl Cancer Inst 99:1248-56. 2007..However, no data on outcomes of testicular cancer survivors with second cancers compared to patients with comparable first cancers exist... - Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based studyMichie Hisada
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 8008, Bethesda, MD 20892 7201, USA
J Natl Cancer Inst 99:215-22. 2007..The available evidence is conflicting, with most risk estimates based on sparse numbers. To our knowledge, no study has evaluated cause-specific mortality in patients with hairy cell leukemia... - Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control studyCatherine Metayer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
Blood 101:2015-23. 2003..Transplantation-related factors may also modulate this risk; however, the apparent contribution of high-dose TBI requires confirmation... - Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational researchJoanne W Elena
Clinical and Translational Epidemiology Branch, DCCPS 6130 Executive Blvd, rm 5136 Bethesda, Maryland 20892
J Natl Cancer Inst 105:85-94. 2013.... - Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrastLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland 20892, USA
Radiat Res 160:691-706. 2003..Nonetheless, the substantial risks associated with liver cancer and leukemia indicate that unique and prolonged exposure to alpha-particle-emitting Thorotrast increased carcinogenic risks... - Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control studyRochelle E Curtis
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7042, 6120 Executive Blvd, Bethesda, MD 20892, USA
Blood 105:3802-11. 2005..Our results also suggest that clinical screening for SCC is appropriate among patients exposed to persistent chronic GVHD, prolonged immunosuppressive therapy, or both... - Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivorsD Michal Freedman
Division of Epidemiology and Genetics, National Cancer Institute, NIH DHHS, Rm 7036 Executive Plaza South, 6120 Executive Boulevard, Bethesda, MD 20892 7238, USA
Neuroepidemiology 25:176-80. 2005..Large cancer registries offer the opportunity to explore and generate hypotheses about the pathogenesis of cancer and other diseases, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS)... - Risk of second malignant neoplasms among lymphoma patients with a family history of cancerOla Landgren
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA
Int J Cancer 120:1099-102. 2007..99, 95% CI: 0.73-5.39). Our observations suggest that genetic factors, as measured by positive family history of cancer, may be influential risk-factors for selected second tumors following lymphoproliferative disorders... - Merkel cell carcinoma and multiple primary cancersRegan A Howard
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
Cancer Epidemiol Biomarkers Prev 15:1545-9. 2006..Heightened awareness of the associations of lymphohematopoietic malignancies with MCC may facilitate early clinical recognition... - Cancer survivorship: facing forwardLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, National Institutes of Health, Bethesda, MD, USA
Hematol Oncol Clin North Am 22:365-71, ix. 2008..In this article, the authors briefly review the history of the efforts that served to coalesce efforts to champion survivorship research, identify future challenges, and provide a perspective on future recommendations... - Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 casesJorge R Toro
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7231, USA
Int J Cancer 119:2922-30. 2006..Incidence patterns of STS varied markedly by histologic type, supporting the notion that these tumors may be etiologically distinct... - Cancer Survivorship. PrefaceLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human ServicesNational Institutes of Health, Bethesda, MD, USA
Hematol Oncol Clin North Am 22:xi-xii. 2008 - The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphomaLinda Morris Brown
Cancer 107:2741-2; author reply 2742. 2006 - Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up surveyUllakarin Nyberg
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Radiat Res 157:419-25. 2002..In addition, there may be a relationship between radiation exposure and the development of other solid tumors... - Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's diseaseFlora E van Leeuwen
Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
J Natl Cancer Inst 95:971-80. 2003..Female survivors of Hodgkin's disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not well known... - Second primary cancers: an overviewAndrea K Ng
Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, ASB1 L2, Boston, MA 02115, USA
Hematol Oncol Clin North Am 22:271-89, vii. 2008..The focus of this article is treatment-associated malignancies in survivors of selected adult cancers... - An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agentsLisa J Worrillow
Leukaemia Research Fund Epidemiology and Genetics Unit, Academic Unit of Epidemiology, School of Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom
Clin Cancer Res 9:3012-20. 2003..MSI was evaluated in presentation bone marrow from 34 cases using the mononucleotide microsatellite markers BAT16, BAT25, and BAT26... - Second primary cancers after thymomaLois B Travis
Int J Cancer 107:868-70. 2003 - Noncancer causes of death in survivors of testicular cancerSophie D Fossa
Department of Clinical Cancer Research, Rikshospitalet Radiumhospitalet Trust, Oslo, Norway
J Natl Cancer Inst 99:533-44. 2007..We conducted a population-based study to quantify the long-term risks of mortality from noncancer causes among men with testicular cancer... - Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. menSophie D Fossa
Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Norway
J Natl Cancer Inst 97:1056-66. 2005..We evaluated the risk of contralateral testicular cancer and survival in a large population-based cohort of men diagnosed with testicular cancer before age 55 years... - Suicide after childhood cancerRegan A Howard
J Clin Oncol 25:731; author reply 733-4. 2007 - Mechanisms of therapy-related carcinogenesisJames M Allan
Epidemiology and Genetics Unit, Department of Biology, University of York, Heslington, York, YO10 5YW, UK
Nat Rev Cancer 5:943-55. 2005..Unsurprisingly, some of these mechanisms seem to operate in the development of sporadic cancers... - Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphomaDavid C Hodgson
Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada
J Clin Oncol 25:1489-97. 2007..However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis... - p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancerDebra G B Leonard
Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
Clin Cancer Res 8:973-85. 2002..The propensity for G-to-A transitions may reflect specific DNA damage in leukemias after treatment with platinum analogues...